Sumitomo Chemical India DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.75×0.75×0.74×0.74×0.77×
1.28×1.20×1.20×1.22×1.06×
18.1%18.7%18.0%14.5%17.5%
0.77×0.77×0.87×0.85×1.10×
1.35×1.32×1.36×1.36×1.41×
18.0%17.0%19.1%15.0%22.3%
17.3%17.3%18.9%15.3%23.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUMICHEM₹331.90

Sumitomo Chemical India Ltd.

· Chemicals
₹ CrorePeersBAYERCROPRALLISPIINDSPLPETROINDOBORAXIGPLOALPCBLMcap ₹16,567 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.770.740.740.750.75
Interest Burden (Pretax/EBIT) ×1.061.221.201.201.28
EBIT Margin %17.5114.5017.9818.6718.14
Asset Turnover ×1.100.850.870.770.77
Financial Leverage (Assets/Equity) ×1.411.361.361.321.35
ROE (5-step product, year-end total equity) %22.2614.9819.1017.0217.97
ROE (owners' profit / average owners' equity) %23.3115.3218.9217.2617.26
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.